Tirzepatide / Guide
Tirzepatide dosage chart: mg, mL and units
Prescriptions say mg and syringes say units. This chart lines up each Mounjaro and Zepbound label dose with its mL and U-100 units.
[00] Short answer
- The label schedule starts at 2.5 mg once a week for 4 weeks, then goes up in 2.5 mg steps at least 4 weeks apart, to a maximum of 15 mg a week1–2.
- At 10 mg/mL, 2.5 mg is 25 units on a U-100 insulin syringe. For any vial, units = dose in mg ÷ strength in mg/mL × 100.
- A Zepbound or Mounjaro single-dose vial holds the dose in 0.5 mL, which is the 50-unit line on a U-100 syringe1–2.
- A missed dose can be taken within 4 days (96 hours). After that, skip it and take the next one on your usual day1–2.
Tirzepatide dose schedule on the label
The tirzepatide label schedule starts at 2.5 mg injected once a week for 4 weeks. The dose then goes up in 2.5 mg steps, with at least 4 weeks on each dose, up to a maximum of 15 mg once a week1–2. Going up slowly is meant to lower the chance of stomach side effects like nausea1.
The Zepbound label says the 2.5 mg dose is only for starting, not for staying on. Its maintenance doses are 5 mg, 10 mg or 15 mg a week for weight reduction, and 10 mg or 15 mg for obstructive sleep apnea2. If a maintenance dose isn't tolerated, the Zepbound label says a lower maintenance dose can be considered2. The Mounjaro label says to raise the dose if more blood sugar control is needed. Its maximum is 15 mg for adults and 10 mg for children aged 10 and older1.
| Weekly dose | Earliest start, if each step lasts 4 weeks | Zepbound maintenance dose? |
|---|---|---|
| 2.5 mg | Week 1 (starting dose, 4 weeks) | No, starting dose only |
| 5 mg | Week 5 or later | Yes, for weight |
| 7.5 mg | Week 9 or later | Not listed as a maintenance dose |
| 10 mg | Week 13 or later | Yes, for weight and sleep apnea |
| 12.5 mg | Week 17 or later | Not listed as a maintenance dose |
| 15 mg | Week 21 or later | Yes, for weight and sleep apnea |
"Earliest start" assumes the shortest step of 4 weeks. The label says at least 4 weeks, so a step can last longer. Your prescriber decides when, or whether, to go up.
Both labels say to inject once a week, at any time of day, with or without food. It goes under the skin of the belly, thigh or back of the upper arm. Change the spot each week1–2.
FDA has had reports of side effects in people prescribed compounded semaglutide or tirzepatide at doses beyond the approved label. That means a bigger single dose, doses more often than weekly, or going up faster than the label schedule. Some people needed medical care for symptoms like nausea, vomiting, diarrhea, stomach pain and constipation3.
Mounjaro and Zepbound pen doses in mL
Mounjaro and Zepbound pens give a set tirzepatide dose, so there are no units to measure. The single-dose pen holds one dose in 0.5 mL. The KwikPen holds 4 weekly doses of 0.6 mL each, 2.4 mL in total1–2.
- Single-dose pen: one pen per week, in 2.5, 5, 7.5, 10, 12.5 or 15 mg1–2.
- KwikPen: one pen covers 4 weekly doses. Each pen is one strength, so a dose change means a new pen. The pen stops you dialing a full dose after the 4th one. The instructions say not to inject the leftover medicine and not to move it into a syringe5.
If you move between a pen and a vial, the mg dose can stay the same while the mL changes. A 5 mg dose is 0.5 mL from a single-dose pen or vial, but 0.6 mL from a KwikPen or multi-dose vial1–2.
How many units is 2.5 mg of tirzepatide?
At 10 mg/mL, 2.5 mg of tirzepatide is 25 units on a U-100 insulin syringe (0.25 mL). The number changes with your vial's strength: at 5 mg/mL it's 50 units, and at 15 mg/mL it's about 16.7 units.
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit is 0.01 mL. A unit here is a mark on the syringe, not an amount of tirzepatide.
- Find the strength on your vial labelLook for mg/mL, for example "10 mg/mL". If it only says a total, like 20 mg in 2 mL, divide: 20 ÷ 2 = 10 mg/mL.
- Divide your dose by the strengthThis gives mL. For 2.5 mg at 10 mg/mL: 2.5 ÷ 10 = 0.25 mL.
- Multiply by 100This gives units on a U-100 syringe. 0.25 mL × 100 = 25 units.
| Dose | 5 mg/mL | 10 mg/mL | 15 mg/mL | 20 mg/mL |
|---|---|---|---|---|
| 2.5 mg | 50 units · 0.5 mL | 25 units · 0.25 mL | 16.7 units · 0.167 mL | 12.5 units · 0.125 mL |
| 5 mg | 100 units · 1 mL | 50 units · 0.5 mL | 33.3 units · 0.333 mL | 25 units · 0.25 mL |
| 7.5 mg | 150 units (1.5 mL), more than a 1 mL syringe | 75 units · 0.75 mL | 50 units · 0.5 mL | 37.5 units · 0.375 mL |
| 10 mg | 200 units (2 mL), more than a 1 mL syringe | 100 units · 1 mL | 66.7 units · 0.667 mL | 50 units · 0.5 mL |
| 12.5 mg | 250 units (2.5 mL), more than a 1 mL syringe | 125 units (1.25 mL), more than a 1 mL syringe | 83.3 units · 0.833 mL | 62.5 units · 0.625 mL |
| 15 mg | 300 units (3 mL), more than a 1 mL syringe | 150 units (1.5 mL), more than a 1 mL syringe | 100 units · 1 mL | 75 units · 0.75 mL |
These strengths are examples of what a compounded vial label might show. They are not recommendations. A 1 mL syringe holds 100 units, and many are marked every 2 units, so figures like 12.5 or 16.7 units fall between lines.
How many mg of tirzepatide is 10, 20 or 50 units?
At 10 mg/mL, 10 units of tirzepatide is 1 mg, 20 units is 2 mg and 50 units is 5 mg. For any vial, multiply the units by the strength in mg/mL, then divide by 100.
Use this to check that the units on a pharmacy label match the mg your prescriber wrote.
| Units drawn | 5 mg/mL | 10 mg/mL | 15 mg/mL | 20 mg/mL |
|---|---|---|---|---|
| 10 units (0.1 mL) | 0.5 mg | 1 mg | 1.5 mg | 2 mg |
| 20 units (0.2 mL) | 1 mg | 2 mg | 3 mg | 4 mg |
| 25 units (0.25 mL) | 1.25 mg | 2.5 mg | 3.75 mg | 5 mg |
| 30 units (0.3 mL) | 1.5 mg | 3 mg | 4.5 mg | 6 mg |
| 40 units (0.4 mL) | 2 mg | 4 mg | 6 mg | 8 mg |
| 50 units (0.5 mL) | 2.5 mg | 5 mg | 7.5 mg | 10 mg |
| 60 units (0.6 mL) | 3 mg | 6 mg | 9 mg | 12 mg |
| 75 units (0.75 mL) | 3.75 mg | 7.5 mg | 11.25 mg | 15 mg |
| 100 units (1 mL) | 5 mg | 10 mg | 15 mg | 20 mg |
Zepbound vial dose in mL and units
A Zepbound single-dose vial holds one dose of tirzepatide in 0.5 mL, at every strength from 2.5 mg to 15 mg2. On a U-100 insulin syringe, 0.5 mL is the 50-unit line. The multi-dose vial holds 4 weekly doses in 2.4 mL, and each dose is 0.6 mL, or 60 units2.
With brand vials, the amount you draw stays the same when your dose goes up. Only the strength printed on the vial changes. Mounjaro comes in the same vial sizes1.
| Dose | Single-dose vial | Multi-dose vial (4 doses) |
|---|---|---|
| 2.5 mg | 2.5 mg/0.5 mL · draw 0.5 mL = 50 units | 10 mg/2.4 mL · draw 0.6 mL = 60 units |
| 5 mg | 5 mg/0.5 mL · draw 0.5 mL = 50 units | 20 mg/2.4 mL · draw 0.6 mL = 60 units |
| 7.5 mg | 7.5 mg/0.5 mL · draw 0.5 mL = 50 units | 30 mg/2.4 mL · draw 0.6 mL = 60 units |
| 10 mg | 10 mg/0.5 mL · draw 0.5 mL = 50 units | 40 mg/2.4 mL · draw 0.6 mL = 60 units |
| 12.5 mg | 12.5 mg/0.5 mL · draw 0.5 mL = 50 units | 50 mg/2.4 mL · draw 0.6 mL = 60 units |
| 15 mg | 15 mg/0.5 mL · draw 0.5 mL = 50 units | 60 mg/2.4 mL · draw 0.6 mL = 60 units |
Strengths and volumes from the US labels, section 3. Units are the same volume shown on a U-100 syringe (1 unit = 0.01 mL).
The Zepbound instructions give the dose in mL: draw to the 0.5 mL line for a single-dose vial, or the 0.6 mL line for a multi-dose vial2. The label says to use a syringe that can measure that amount, such as a 1 mL syringe. Use a new syringe and needle every time2. Use the syringe your prescriber or pharmacist recommends.
What if you miss a tirzepatide dose?
Take a missed tirzepatide dose as soon as you can, as long as it's within 4 days (96 hours). That's the rule on both the Mounjaro and Zepbound labels. If more than 4 days have passed, skip it and take the next one on your usual day1–2.
You can move your injection day, as long as there are at least 3 days (72 hours) between two doses1–2. For worked examples and other GLP-1 medicines, see our missed GLP-1 dose guide.
Mounjaro pen doses in the UK
In the UK, tirzepatide comes as the Mounjaro KwikPen. Each pen holds 4 fixed doses of 0.6 mL, at strengths from 2.5 mg to 15 mg per dose4. You turn the knob until it stops, so there are no units or mL to work out.
The UK dose steps match the US: 2.5 mg for 4 weeks, then 5 mg, then 2.5 mg steps at least 4 weeks apart, up to 15 mg4. Read Mounjaro pen doses in the UK for pen sizes, leftover liquid and why the pen isn't made for partial doses.
Questions
How many units is 5 mg of tirzepatide?
At 10 mg/mL, 5 mg is 50 units on a U-100 insulin syringe. At other strengths it's 100 units (5 mg/mL), about 33.3 units (15 mg/mL) or 25 units (20 mg/mL). Check the mg/mL on your own vial.
Is 0.5 mL the same as 50 units?
Yes, on a U-100 insulin syringe. 100 units equals 1 mL, so 0.5 mL is the 50-unit line. That's the volume in a Zepbound or Mounjaro single-dose vial.
What is the highest dose of tirzepatide?
The Mounjaro and Zepbound labels set a maximum of 15 mg once a week for adults. For children aged 10 and older with type 2 diabetes, the Mounjaro maximum is 10 mg a week.
Can I change the day I take tirzepatide?
Yes. Both US labels say you can change your weekly day as long as there are at least 3 days (72 hours) between two doses.
How long can I use an opened multi-dose vial?
Brand Zepbound and Mounjaro multi-dose vials are thrown away after 4 weekly doses or 30 days after first use. For compounded multi-dose vials, FDA recommends throwing them away 28 days after first use, even if medicine is left.
Why does my compounded vial need a different number of units than my friend's?
Because the two vials have different strengths. The same 2.5 mg dose is 50 units at 5 mg/mL but 25 units at 10 mg/mL. Go by the strength printed on your own vial.
Sources
Checked against the Mounjaro and Zepbound US prescribing information (revised 08/2026) and FDA's page on compounded GLP-1 drugs. How we check
- 1Mounjaro (tirzepatide) injection: US prescribing information, Eli Lilly (DailyMed, revised 08/2026). sections 2.1, 2.2 and 3
- 2Zepbound (tirzepatide) injection: US prescribing information and Instructions for Use, Eli Lilly (DailyMed, revised 08/2026). sections 2.1 to 2.4, 3 and 16.2; single-dose and multi-dose vial Instructions for Use
- 3FDA: FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. dosing concerns and multi-dose vials; content current as of October 1, 2026
- 4Mounjaro KwikPen solution for injection in pre-filled pen: Summary of Product Characteristics (emc, revised August 29, 2026). sections 2 and 4.2
- 5Mounjaro KwikPen (tirzepatide): US Instructions for Use, Eli Lilly (revised January 2026). important information and storing sections
This guide explains what labels and published studies say. It isn't medical advice and doesn't replace your prescriber or pharmacist.
Spotted a mistake or something out of date? Tell us. We aim to fix factual errors within two working days.